A Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Adps in the Treatment of Acne Vulgaris
Phase of Trial: Phase II
Latest Information Update: 08 May 2017
At a glance
- Drugs ADPS (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 03 May 2017 Status changed from active, no longer recruiting to completed.
- 16 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 02 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.